CRISPR: a revolutionary tool for modeling and treating cancer and Duchenne muscular dystrophy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Главный автор: | Eva, Israt Ara Jannat |
---|---|
Другие авторы: | Rahman, Kazi Fatema |
Формат: | Диссертация |
Язык: | English |
Опубликовано: |
Brac University
2023
|
Предметы: | |
Online-ссылка: | http://hdl.handle.net/10361/17764 |
Схожие документы
-
A review on CRISPR-Cas system based applications in Oncology
по: Sadia, Mir
Опубликовано: (2022) -
CRISPR/Cas9 system: A versatile gene editing tool in disease prevention and treatment
по: Maria, Amatul
Опубликовано: (2020) -
Comparative analysis of CRISPR-Cas systems of Yersinia pestis and Escherichia coli strains. (November 2020 – December 2021)
по: Nwabunwanne, Eze Uchenna
Опубликовано: (2022) -
Prevalence and application of an evolving genome editing tool “CRISPR/Cas System” in cancer research and treatment
по: Shaikat, Mahdi Mubin
Опубликовано: (2023) -
CRISPR/Cas9 genome editing to treat sickle cell disease
по: Ullah, Mohammad
Опубликовано: (2023)